Journals / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 6

The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children

Pages
628–633
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This decrease was most pronounced in cases of Rotavirus diarrhea.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: In contrast to many other studies of probiotic species, the number of publications evaluating Bifidobacterium lactis and its combinations with prebiotics as treatments for acute infectious diarrhea is limited.
📊
Key Findings & Data:We investigated the synbiotic effects of B. lactis B94 plus inulin on acute infectious diarrhea.Materials and Methods: The study was conducted on children with acute diarrhea between the ages of 2 and 60 months.
💡
Conclusion & Impact:This decrease was most pronounced in cases of Rotavirus diarrhea.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: In contrast to many other studies of probiotic species, the number of publications evaluating Bifidobacterium lactis and its combinations with prebiotics as treatments for acute infectious diarrhea is limited. We investigated the synbiotic effects of B. lactis B94 plus inulin on acute infectious diarrhea.Materials and Methods: The study was conducted on children with acute diarrhea between the ages of 2 and 60 months. The patients were administered 5×1010 colony-forming units (CFU) of B. lactis B94 plus 900 mg inulin or placebo, once a day for five days. Stools were examined for Rotavirus, Adenovirus, Entamoeba histolytica, Salmonella, Shigella, Campylobacter, Clostridium difficile, Cryptosporidium, and parasites.Results: We examined 79 patients in the synbiotic group and 77 patients in the placebo group. The duration of diarrhea was significantly reduced in the synbiotic group in comparison with the placebo group (3.9±1.2 days vs. 5.2±1.3 days, respectively; p<0.001). Moreover, the number of diarrheal stools on the third day was significantly lower in the synbiotic group than in the placebo group (5.5±2.9 vs. 8.3±3.01, respectively; p<0.001). Diarrhea in the synbiotic-group patients with rotavirus infection was of a significantly shorter duration (3.2±1.3 days vs. 5.2±1.3 days, respectively; p=0.001). Duration of diarrhea in patients who started the synbiotic treatment within the first 24 h was shorter than that in the patients who started the treatment later (3.9±1.1 days vs. 4.8±1.8 days, respectively; p=0.002).Conclusion: Treatment with 5 × 1010 CFU of B. lactis B94 plus 900 mg inulin shortened the duration of acute watery diarrhea by an average of 31 h. This decrease was most pronounced in cases of Rotavirus diarrhea.

🔖

Cite This Article

İSLEK, A., SAYAR, E., YILMAZ, A., BAYSAN, B. Ö., MUTLU, D., ARTAN, R. (2014). The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 6, 628–633. https://ajindex.com/articles/409542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Koletzko S, Osterrieder S. Acute infectious diarrhea in children. Dtsch Arzetbl Int 2009; 106: 539-47
  2. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 20; 381: 1405-16
  3. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-14
  4. Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des 2005; 11: 55-74
  5. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006; 43: 550-7
  6. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014; 58: 531-9
  7. De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 2006; 23: 963-74
  8. Cabana MD, Shane AL, Chao C, Oliva-Henker M. Probiotics in primary care pediatrics. Clin Pediatr 2006; 45: 405-10
  9. Fedorak RN, Madsen KI. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 2004; 20: 146-55
  10. Michail S, Abernathy F. Lactobacillus plantarum reduces thein vitro secretory response of intestinal epithelial cells in enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 2002; 35: 350-5
  11. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10: 55-64
  12. Arunachalam K, Gill HS, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacteria lactis (HN019). Eur J Clin Nutr 2000; 54: 263- 7
  13. Kalia M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4
  14. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious